Subtopic Deep Dive
Platinum Drug Resistance Mechanisms
Research Guide
What is Platinum Drug Resistance Mechanisms?
Platinum drug resistance mechanisms are cellular processes including DNA repair, efflux transport, and glutathione conjugation that reduce cisplatin efficacy in cancer cells.
These mechanisms limit the clinical success of platinum-based chemotherapies like cisplatin in treating ovarian, lung, and testicular cancers. Key pathways involve enhanced nucleotide excision repair (NER) and overexpression of transporters like MRP2. Over 10,000 papers document these processes, with foundational works citing DNA-adduct formation and repair (Dasari and Tchounwou, 2014; 5273 citations; Galluzzi et al., 2011; 2693 citations).
Why It Matters
Understanding resistance enables combination therapies targeting efflux pumps or DNA repair to resensitize refractory tumors, improving survival in ovarian cancer patients (Wheate et al., 2010; 1594 citations). It guides development of next-generation platinum analogs with reduced resistance profiles, as seen in ruthenium complexes like KP1019 (Hartinger et al., 2006; 949 citations). Insights from proteomics of resistant cell lines inform personalized medicine, reducing toxicity in non-resistant tissues (Florea and Büsselberg, 2011; 1720 citations).
Key Research Challenges
Heterogeneity in Resistance Pathways
Tumors exhibit variable resistance due to genomic instability and microenvironment factors across cancer types. Galluzzi et al. (2011; 2693 citations) identify diverse mechanisms like NER upregulation and apoptosis evasion. Standardizing models for multi-pathway resistance remains difficult (Florea and Büsselberg, 2011; 1720 citations).
Efflux Transporter Overexpression
ATP-binding cassette transporters like MRP2 expel platinum drugs, reducing intracellular accumulation. Wheate et al. (2010; 1594 citations) note this limits cisplatin in ovarian and lung cancers. Inhibitor combinations often fail due to compensatory pathways.
Glutathione-Mediated Detoxification
Elevated glutathione conjugates cisplatin, neutralizing its DNA-binding activity. Dasari and Tchounwou (2014; 5273 citations) detail conjugation as a primary resistance factor. Targeting glutathione synthesis shows promise but induces toxicity (Galluzzi et al., 2011; 2693 citations).
Essential Papers
Cisplatin in cancer therapy: Molecular mechanisms of action
Shaloam Dasari, Paul Bernard Tchounwou · 2014 · European Journal of Pharmacology · 5.3K citations
Molecular mechanisms of cisplatin resistance
Lorenzo Galluzzi, Laura Senovilla, Ilio Vitale et al. · 2011 · Oncogene · 2.7K citations
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
Ana-Maria Florea, Dietrich Büsselberg · 2011 · Cancers · 1.7K citations
Platinum complexes are clinically used as adjuvant therapy of cancers aiming to induce tumor cell death. Depending on cell type and concentration, cisplatin induces cytotoxicity, e.g., by interfere...
Cisplatin: The first metal based anticancer drug
Sumit Ghosh · 2019 · Bioorganic Chemistry · 1.6K citations
The status of platinum anticancer drugs in the clinic and in clinical trials
Nial Wheate, Shonagh Walker, Gemma E. Craig et al. · 2010 · Dalton Transactions · 1.6K citations
Since its approval in 1979 cisplatin has become an important component in chemotherapy regimes for the treatment of ovarian, testicular, lung and bladder cancers, as well as lymphomas, myelomas and...
From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
Christian G. Hartinger, Stefanie Zorbas‐Seifried, Michael A. Jakupec et al. · 2006 · Journal of Inorganic Biochemistry · 949 citations
New metal complexes as potential therapeutics
Christiana Xin Zhang, Stephen J. Lippard · 2003 · Current Opinion in Chemical Biology · 935 citations
Reading Guide
Foundational Papers
Start with Dasari and Tchounwou (2014; 5273 citations) for cisplatin mechanisms, then Galluzzi et al. (2011; 2693 citations) for resistance pathways, and Florea and Büsselberg (2011; 1720 citations) for cellular details.
Recent Advances
Rottenberg et al. (2020; 917 citations) on therapy rediscovery; Ghosh (2019; 1639 citations) on cisplatin history; Ndagi et al. (2017; 879 citations) on metal complex design.
Core Methods
Nucleotide excision repair assays, efflux transporter qPCR/Western blots, glutathione quantification via HPLC, cisplatin accumulation by atomic absorption spectroscopy.
How PapersFlow Helps You Research Platinum Drug Resistance Mechanisms
Discover & Search
Research Agent uses searchPapers with query 'cisplatin resistance glutathione NER' to retrieve Dasari and Tchounwou (2014; 5273 citations), then citationGraph maps efflux studies from Wheate et al. (2010), and findSimilarPapers expands to ruthenium alternatives like Hartinger et al. (2006). exaSearch drills into proteomics datasets from resistant cell lines.
Analyze & Verify
Analysis Agent applies readPaperContent to Galluzzi et al. (2011) for NER pathway details, verifyResponse with CoVe cross-checks claims against Florea and Büsselberg (2011), and runPythonAnalysis processes dose-response data from abstracts using pandas for IC50 curves. GRADE grading scores evidence strength for DNA repair claims.
Synthesize & Write
Synthesis Agent detects gaps in efflux-glutathione interactions across papers, flags contradictions in resistance timelines (2011 vs. 2020), and Writing Agent uses latexEditText for mechanism diagrams, latexSyncCitations for 50+ refs, latexCompile for publication-ready reviews, with exportMermaid for pathway flowcharts.
Use Cases
"Extract dose-response data from cisplatin resistance papers and plot survival curves"
Research Agent → searchPapers('cisplatin IC50 resistant cells') → Analysis Agent → readPaperContent(Florea 2011) → runPythonAnalysis(pandas plot IC50 vs. cell lines) → matplotlib survival curve output.
"Write LaTeX review on platinum resistance mechanisms with citations"
Synthesis Agent → gap detection(Dasari 2014 + Galluzzi 2011) → Writing Agent → latexEditText(draft NER section) → latexSyncCitations(10 papers) → latexCompile → PDF with diagrams.
"Find code for simulating platinum-DNA adduct formation"
Research Agent → searchPapers('platinum DNA adduct simulation') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(test molecular dynamics script).
Automated Workflows
Deep Research workflow scans 50+ papers on 'platinum resistance mechanisms' via searchPapers → citationGraph → structured report with GRADE-scored sections on NER and efflux. DeepScan applies 7-step analysis: readPaperContent(Galluzzi 2011) → CoVe verify → runPythonAnalysis(proteomics) → gap synthesis. Theorizer generates hypotheses linking glutathione levels to KP1019 sensitivity from Hartinger et al. (2006).
Frequently Asked Questions
What defines platinum drug resistance mechanisms?
Cellular adaptations like enhanced DNA repair (NER), drug efflux via MRP2/ABCC2, and glutathione conjugation reduce cisplatin-DNA adducts and cytotoxicity (Dasari and Tchounwou, 2014; Galluzzi et al., 2011).
What are main methods to study these mechanisms?
Genomics/proteomics in resistant cell lines measure transporter expression; comet assays quantify DNA damage; siRNA knockdown validates pathways like NER (Florea and Büsselberg, 2011).
What are key papers on the topic?
Dasari and Tchounwou (2014; 5273 citations) on action mechanisms; Galluzzi et al. (2011; 2693 citations) on resistance details; Wheate et al. (2010; 1594 citations) on clinical status.
What open problems exist?
Overcoming tumor heterogeneity in resistance; developing non-toxic efflux inhibitors; predicting patient-specific mechanisms via biomarkers (Rottenberg et al., 2020; Wheate et al., 2010).
Research Metal complexes synthesis and properties with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Platinum Drug Resistance Mechanisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers